Recombinant CD27 (Varlilumab Biosimilar) antibody

Catalog No. ABIN7598084

This anti-CD27 (Varlilumab Biosimilar) antibody is a Human Monoclonal antibody detecting CD27 (Varlilumab Biosimilar) in . Suitable for Human.

Quick Overview for Recombinant CD27 (Varlilumab Biosimilar) antibody (ABIN7598084)

Target: CD27 (Varlilumab Biosimilar)

Antibody Type: Recombinant Antibody

Reactivity: Human

Host: Human

Clonality: Monoclonal

Conjugate: This CD27 (Varlilumab Biosimilar) antibody is un-conjugated

Application: Please inquire

Grade: Research Grade

Product Details anti-CD27 (Varlilumab Biosimilar) Antibody

Expression System: Mammalian cells

Purpose: Research Grade Varlilumab Biosimilar Antibody

Specificity: CD27L receptor, TNFRSF7, T14, CD27 antigen, Tumor necrosis factor receptor superfamily member 7, CD27, T-cell activation antigen CD27

Purification: Protein A or G purified from cell culture supernatant.

Purity: >95 % by SDS-PAGE.

Isotype: IgG1 kappa

Application Details

Restrictions: For Research Use only

Handling

Format: Liquid

Concentration: 2 mg/mL

Buffer: 0.01M PBS, pH 7.4.

Storage: 4 °C,-20 °C,-80 °C

Storage Comment: Use a manual defrost freezer and avoid repeated freeze-thaw cycles.Store at +4°C short term (1-2 weeks).Store at -20 °C 12 months. Store at -80°C long term.

Expiry Date: 12 months

Target Details for CD27 (Varlilumab Biosimilar)

Target: CD27 (Varlilumab Biosimilar)

Alternative Name: Varlilumab Biosimilar

Target Type: Biosimilar

Background: CD27L receptor, TNFRSF7, T14, CD27 antigen, Tumor necrosis factor receptor superfamily member 7, CD27, T-cell activation antigen CD27

UniProt: P26842

CAS-No: 1393344-72-3